Shizuoka Cancer Center

Sunto, Shizuoka 411-8777

1 studies enrolling now · 5 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, Advanced Solid Tumor, Colorectal Cancer, EGFR Mutation, Gastric Cancer, Gastroesophageal Junction Cancer, HER2 Mutation, MTAP-deleted Solid Tumors, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma

Studies at this site

• First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors — Recruiting now
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas — Completed